Message from the Director, Dr. Mehrdad Shamloo
As part of the Stanford Neurosciences Institute, BFNL provides a preclinical discovery platform for CNS target validation in preclinical in vivo and in vitro models. Our well validated neurobehavioral assessment tools in CNS disease models provide a unique platform for the screening and profiling of experimental therapeutics and genetic rodent models. We aim to accelerate the progress in both fundamental and applied studies of nervous system function. We collaborate with academic laboratories, non-profit foundations, and biopharmaceutical companies worldwide to support the understanding of human CNS disorders and develop therapeutic interventions. More about us...
SBFNL will exhibit at SfN's 47th Annual Neuroscience Meeting on November 11-15, 2017 at the Walter E. Washington Convention Center. Washington, DC.
Booth number 3926!
Visit us at the exhibit to explore our services, discuss your projects, and find out how we can help your research move forward faster.